Search Results for keywords:"National Institute of Diabetes and Digestive and Kidney Diseases"

The National Institute of Diabetes and Digestive and Kidney Diseases announced a closed meeting for their Special Emphasis Panel on April 11, 2025, from 11:00 a.m. to 12:30 p.m. This meeting will be conducted virtually and will focus on reviewing and evaluating grant applications. The meeting is closed to the public to prevent the disclosure of confidential information such as trade secrets, patentable material, and personal information of individuals associated with the grants. For more details, Dr. Xiaodu Guo can be contacted via email at guox@extra.niddk.nih.gov.

The National Institute of Diabetes and Digestive and Kidney Diseases will hold a closed meeting for the review and evaluation of grant applications from February 13-14, 2025. The meeting will be virtual, and it is closed to the public because it involves discussions that might reveal confidential information or personal details. The contact person for this meeting is Dr. Jian Yang. This meeting is part of the work undertaken by the National Institutes of Health under the Department of Health and Human Services.

The National Institute of Diabetes and Digestive and Kidney Diseases Advisory Council is holding a meeting on April 24, 2025, as announced under the Federal Advisory Committee Act. This meeting will be open to the public from 4:00 p.m. to 4:30 p.m. for general council business, followed by various closed sessions to review grant applications related to diabetes, endocrine, digestive, nutrition, kidney, and urologic research. The meeting will be held virtually, and those needing special accommodations are advised to contact Karl F. Malik in advance. More information can be found on the Institute's website.

The National Institute of Diabetes and Digestive and Kidney Diseases is holding a closed meeting on March 19-20, 2025, to review and evaluate grant applications. The meeting is confidential to protect sensitive trade secrets, commercial property, and personal information. It will be conducted virtually from the National Institutes of Health in Bethesda, MD. For more details, Peter J. Kozel can be contacted via email or phone.

The National Institute of Diabetes and Digestive and Kidney Diseases has announced a closed meeting scheduled for April 13, 2021. This meeting, held virtually, will review and evaluate grant applications, and it is closed to the public to protect sensitive information. The meeting will be from 2:00 p.m. to 4:30 p.m. and involves discussions that could reveal confidential trade secrets or personal information. Maria E. Davila-Bloom is the contact person for further details.

The National Institute of Diabetes and Digestive and Kidney Diseases is having a closed meeting to review and evaluate grant applications on March 17-18, 2021. The meeting, conducted virtually, will discuss sensitive information that could involve trade secrets or private data related to individuals connected with the grant applications. This is in accordance with federal laws to protect such confidential information. Dr. Ann A. Jerkins is the contact person for the meeting.

The National Institute of Diabetes and Digestive and Kidney Diseases is holding a closed meeting on February 27, 2025, from 10:00 a.m. to 12:30 p.m., to review and evaluate grant applications. The meeting will be conducted virtually and is being closed to the public to protect confidential information, including trade secrets and personal privacy related to the grant applications. Dr. Jian Yang will serve as the Scientific Review Officer for this meeting. The notice was filed by Lauren A. Fleck, a Program Analyst at the Office of Federal Advisory Committee Policy.

The National Institutes of Health announced a closed meeting held by the National Institute of Diabetes and Digestive and Kidney Diseases. This meeting, scheduled for March 12-13, 2025, will take place both in person and virtually at the Embassy Suites in Washington, DC. Its purpose is to review and evaluate grant applications, and it will be closed to the public to protect confidential and personal information. The meeting highlights the importance of confidentiality in discussions involving trade secrets and personal privacy.

The National Institutes of Health is holding a closed virtual meeting organized by the National Institute of Diabetes and Digestive and Kidney Diseases. The meeting, scheduled for May 2, 2025, will focus on evaluating grant applications related to diabetes research, specifically the proteomic mapping of diabetic pathophysiology and therapeutic pathways. This session is closed to the public to protect confidential trade secrets, commercial property, and personal information. The meeting will be hosted online, and inquiries can be directed to Dr. Paul A. Rushing, the designated contact.

The National Institute of Diabetes and Digestive and Kidney Diseases has announced a meeting that will not be open to the public. This closed meeting will take place on March 31, 2021, and is being held virtually in Bethesda, Maryland. The primary purpose of the meeting is to review and assess grant applications that include sensitive topics such as trade secrets and personal information. Dr. Ryan G. Morris will be the contact person for the event, which involves evaluating applications for research related to diabetes, digestive diseases, and kidney health.